Angiogenic and immune-related biomarkers and outcomes following axitinib/pembrolizumab treatment in patients with advanced renal cell carcinoma
Martini, J. F., et al. Angiogenic and immune-related biomarkers and outcomes following axitinib/pembrolizumab treatment in patients with advanced renal cell carcinoma. Clinical Cancer Research. 2020 AUG 18; DOI: 10.1158/1078-0432.CCR-20-1408
- Categories
- Peer Reviewed Publications